Added to YB: 2025-01-14
Pitch date: 2025-01-11
TMO [bullish]
Thermo Fisher Scientific Inc.
+6.21%
current return
Author Info
No bio for this author
Company Info
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
Market Cap
$215.6B
Pitch Price
$542.26
Price Target
668.00 (+17%)
Dividend
0.30%
EV/EBITDA
21.88
P/E
33.14
EV/Sales
5.67
Sector
Life Sciences Tools and Services
Category
growth
Thermo Fisher Scientific Inc. – Uniquely positioned for long-term success (A Deep Dive)
TMO: High-quality compounder in healthcare/pharma. 83% recurring revenue, 15% market share. 7-9% long-term revenue CAGR, mid-teens EPS growth. Strong moat, M&A focus. Q3 flat revenue but accelerating growth. $668 price target for 2026, 11% annual return potential. Buy below $540-550.
Read full article (14 min)